The founder and CEO of AxoMax Technologies, Inc. is Dr. Kacey Marra. Dr. Marra is tenured full Professor in the Departments of Plastic Surgery (primary) and Bioengineering (secondary), as well as Vice Chair of Research in the Department of Plastic Surgery at the University of Pittsburgh. She is also a core faculty member in the McGowan Institute for Regenerative Medicine, where she has served as a member of the Executive Committee since 2004. After earning her PhD in organic chemistry in 1996 from the University of Pittsburgh, she was a post-doctoral fellow for Elliot Chaikof at Emory University. Following four years as a research scientist at Carnegie Mellon University conducting bone tissue engineering research, she became the director of Plastic Surgery Research at the University of Pittsburgh. She has a publication record of over 150 peer-reviewed articles and over 600 abstracts in the areas of peripheral nerve repair, adipose stem cells, bioreactors, tissue engineering, wound healing, adipose stem cells, and diabetes. Her funding includes NIH, NSF, and DoD grants in the area of regenerative medicine, (including the Armed Forces Institute for Regenerative Medicine, (AFIRM)). She is the Enabling Technology Core Focus Area Leader in AFIRM II. She was Co-Chair of the 2015 Tissue Engineering and Regenerative Medicine International Society (TERMIS) World Congress, held in Boston. She served on the CDMRP PRORP Steering Committee from 2015-2018.